Allogene Therapeutics Inc (ALLO) COM USD0.001
1.07%- This stock can be held in a
Stocks and Shares ISASell:$1.17
Buy:$1.18
Change:
$0.02
(1.25%)
$0.02
(1.25%)Market closed | Prices delayed by at least 15 minutes
Sell:$1.17
Buy:$1.18
Change:$0.02
(1.25%)
$0.02
(1.25%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 21 April 2025 | Annie YoshiyamaSenior Vice President | Sell Tax related | 9,601 | $1.41 | $13,537.41 | 130,663 |
| 14 March 2025 | David D ChangChairman/CEO | Sell Tax related | 46,668 | $1.96 | $91,469.28 | 5,276,569 |
| 14 March 2025 | Benjamin Machinas (Ben) BeneskiCTO | Sell Tax related | 5,488 | $1.98 | $10,838.80 | 218,507 |
| 18 February 2025 | Deborah M. (Debbie) MessemerIndependent Director | Sell Regular sell transaction (market) | 13,313 | $2.43 | $32,350.59 | 144,316 |
| 3 February 2025 | David D ChangChairman/CEO | Sell Tax related | 46,003 | $1.68 | $77,285.04 | 5,317,237 |
| 3 February 2025 | Geoffrey M ParkerCFO | Sell Tax related | 4,361 | $1.73 | $7,544.53 | 1,301,540 |
| 3 February 2025 | Zachary J. RobertsExecutive Vice President | Sell Tax related | 18,832 | $1.70 | $32,014.40 | 643,135 |
| 3 February 2025 | Earl Martin DouglasGeneral Counsel | Sell Tax related | 6,404 | $1.71 | $10,950.84 | 587,848 |
| 3 February 2025 | Timothy L MooreCTO | Sell Tax related | 14,746 | $1.71 | $25,215.66 | 250,713 |
| 21 January 2025 | Zachary J. RobertsExecutive Vice President | Sell Tax related | 27,199 | $1.78 | $48,414.22 | 488,054 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 16 May 2024 | VIDA VENTURES LLCVenture Capital | Buy Regular purchase transaction | 1,724,137 | $2.90 | $4,999,997.30 | 1,724,137 |
| 16 May 2024 | David D ChangChairman/CEO | Buy Regular purchase transaction | 344,828 | $2.90 | $1,000,001.20 | 4,810,106 |
| 16 May 2024 | Geoffrey M ParkerCFO | Buy Regular purchase transaction | 344,828 | $2.90 | $1,000,001.20 | 1,164,418 |
| 16 May 2024 | Arie S. BelldegrunExecutive Chairman | Buy Regular purchase transaction | 344,828 | $2.90 | $1,000,001.20 | 539,867 |
| 21 October 2024 | Geoffrey M ParkerCFO | Sell Tax related | 36,404 | $2.84 | $103,387.36 | 1,131,988 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.